Date | Compound | Laboratory | Indication | Type of Information |
---|---|---|---|---|
2014-02-06 | T cell receptor (TCR) peptide (BV5S2, BV6S5, BV13S1) vaccine | Immune Response BioPharma (USA - NJ) | pediatric multiple sclerosis |
Granting of the orphan status in the US |
2014-10-15 | N-Methanocarbathymidine | N & N Pharmaceuticals (USA - MD) | neonatal herpes |
Granting of the orphan status in the US |
2014-07-10 | adalimumab | Mucora (Israel) | Behcet's disease | Granting of the orphan status in the US |
2018-03-27 | adeno-associated virus serotype 9 expressing the human Survival Motor Neuron gene | AveXis (USA - TX) | spinal muscular atrophy | Granting of the Breakthrough Therapy status |
2014-11-17 | veltuzumab | Immunomedics (USA - NJ) | pemphigus |
Granting of the orphan status in the US |
2014-10-01 | Theranost 68 Ga RGD | Advanced Imaging Projects (USA - FL) | Moyamoya disease |
Granting of the orphan status in the US |
2017-08-29 | benznidazole | Chemo Research (Spain) | Chagas disease | Granting of a Market Authorisation in the US |
2016-02-05 | mesencephalic-astrocyte-derived neurotrophic factor | Amarantus BioScience (USA - CA) | retinitis pigmentosa |
Granting of the orphan status in the US |
2014-10-20 | non-replicating recombinant adeno-associated virus vector containing a fragment of the gene encoding channel rhodopsin-2 protein | RetroSense Therapeutics (USA - MI) | retinitis pigmentosa |
Granting of the orphan status in the US |
2015-01-27 | recombinant human fucosyltransferase VI [ FTVI ] + GDP-fucose | TargaZyme (USA - CA) | prevention of graft-versus-host disease in patients undergoing hematopoietic stem cell transplantation |
Granting of the orphan status in the US |
2015-02-10 | omeprazole-lansoprazole with buffer | Effexus Pharmaceuticals (USA - KS) | esophageal ulcers |
Granting of the orphan status in the US |
2015-04-24 | pelareorep (human reovirus type 3 Dearing strain) | Oncolytics Biotech (Canada) | ovarian cancer |
Granting of the orphan status in the EU |
2015-01-26 | 18Fluorine-N-3-Fluoropropyl-2beta-carbomethoxy-3beta-(4-iodophenyl) Nortropane | Advanced Imaging Projects (USA - FL) | diagnostic to be used in the management of multiple system atrophy (MSA) |
Granting of the orphan status in the US |
2015-01-26 | 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-l-yl)-1-(1-(3-fluoro-2-(trifluoromethyl)isonicotinoyl)piperidin-4-yl)azetidin-3-yl)acetonitrile adipate | Incyte (USA - DE) | pancreatic cancer |
Granting of the orphan status in the US |
2015-01-20 | Baxter (USA - IL) | continuous renal replacement therapy |
Granting of a Market Authorisation in the US | |
2015-01-21 | 8-(1-Hydroxy-ethyl)-2-methoxy-3-(4-methoxy-benzyloxy)-benzo[c]chromen-6-one | RestorGenex (USA - IL) | glioblastoma multiforme |
Granting of the orphan status in the US |
2015-02-05 | ibrutinib | Pharmacyclics (USA - CA) | splenic marginal zone lymphoma |
Positive opinion for the granting of the orphan status in the EU |
2015-02-05 | ibrutinib | Pharmacyclics (USA - CA) | nodal marginal zone lymphoma |
Granting of the orphan status in the US |
2015-01-26 | double stranded RNA which targets the mutated KRAS oncogene | Silenseed (Israel) | pancreatic cancer |
Granting of a patent |
2015-02-03 | bortezomib | Millennium Pharmaceuticals (USA - MA) | acute lymphoblastic leukemia |
Granting of the orphan status in the US |
© 2024 Biopharmanalyses - Powered by Samacom+